WHO assesses active versus passive screening for TB (tuberculosis):
This article was originally published in Clinica
Executive Summary
Dedicated TB case-finding interventions, as opposed to "passive" assessments of symptomatic cases, can improve the speed of diagnosis, but not the rate of detection. So suggest the findings of research conducted for the World Health Organization in southern Ethiopia, comparing TB screening strategies in rural community settings. Treatment outcomes from the two strategies were comparable, concluded the study, which appears in the WHO's February 2006 bulletin.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.